Elevate Uranium Ltd
Elevate Uranium Ltd Fundamental Analysis
Elevate Uranium Ltd (ELVUF) shows moderate financial fundamentals with a PE ratio of -10.56, profit margin of -14.30%, and ROE of -32.33%. The company generates $0.0B in annual revenue with strong year-over-year growth of 4221.52%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of -1054.9/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze ELVUF's fundamental strength across five key dimensions:
Efficiency Score
WeakELVUF struggles to generate sufficient returns from assets.
Valuation Score
ExcellentELVUF trades at attractive valuation levels.
Growth Score
ModerateELVUF shows steady but slowing expansion.
Financial Health Score
ExcellentELVUF maintains a strong and stable balance sheet.
Profitability Score
WeakELVUF struggles to sustain strong margins.
Key Financial Metrics
Is ELVUF Expensive or Cheap?
P/E Ratio
ELVUF trades at -10.56 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, ELVUF's PEG of -0.32 indicates potential undervaluation.
Price to Book
The market values Elevate Uranium Ltd at 2.63 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at -12.96 times EBITDA. This is generally considered low.
How Well Does ELVUF Make Money?
Net Profit Margin
For every $100 in sales, Elevate Uranium Ltd keeps $-14.30 as profit after all expenses.
Operating Margin
Core operations generate -14.40 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-32.33 in profit for every $100 of shareholder equity.
ROA
Elevate Uranium Ltd generates $-24.09 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Elevate Uranium Ltd generates limited operating cash flow of $-8.77M, signaling weaker underlying cash strength.
Free Cash Flow
Elevate Uranium Ltd generates weak or negative free cash flow of $-9.16M, restricting financial flexibility.
FCF Per Share
Each share generates $-0.02 in free cash annually.
FCF Yield
ELVUF converts -9.56% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-10.56
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-0.32
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.63
vs 25 benchmark
P/S Ratio
Price to sales ratio
137.21
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.009
vs 25 benchmark
Current Ratio
Current assets to current liabilities
29.72
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.32
vs 25 benchmark
ROA
Return on assets percentage
-0.24
vs 25 benchmark
ROCE
Return on capital employed
-0.25
vs 25 benchmark
How ELVUF Stacks Against Its Sector Peers
| Metric | ELVUF Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -10.56 | 21.19 | Better (Cheaper) |
| ROE | -32.33% | 948.00% | Weak |
| Net Margin | -1429.95% | -73259.00% (disorted) | Weak |
| Debt/Equity | 0.01 | -0.48 (disorted) | Distorted |
| Current Ratio | 29.72 | 6.31 | Strong Liquidity |
| ROA | -24.09% | -10913945.00% (disorted) | Weak |
ELVUF outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Elevate Uranium Ltd's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
1012088.93%
Industry Style: Cyclical, Value, Commodity
High GrowthEPS CAGR
-117.34%
Industry Style: Cyclical, Value, Commodity
DecliningFCF CAGR
-134.12%
Industry Style: Cyclical, Value, Commodity
Declining